Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor

Cell

Volumn 93, Issue 1, 1998, Pages 111-123

  Lebrón, José A ^a   Bennett, Melanie J ^a   Vaughn, Daniel E ^a,c   Chirino, Arthur J ^a   Snow, Peter M ^a   Mintier, Gabriel A ^b   Feder, John N ^b   Bjorkman, Pamela J ^a  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^b Progenitor Inc   (United States)

^c Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IRON; TRANSFERRIN RECEPTOR;

ANIMAL CELL; HEMOCHROMATOSIS; IRON METABOLISM; IRON OVERLOAD; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; RECEPTOR AFFINITY; RECEPTOR BINDING; REVIEW; STOICHIOMETRY;

EID: 0032478524     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81151-4     Document Type: Article

References (50)

1. Bacon, B.R., and Tavill, A.S. (1996). Hepatology: A Textbook of Liver Disease. (Philadelphia: Saunders).
2. Bebbington, C.R., and Hentschel, C.C.G. (1987). DNA Cloning. (Oxford: IRL).
3. Beckman, E.M., Porcelli, S.A., Morita, C.T., Behar, S.M., Furlong, S.T., and Brenner, M.B. (1994). Recognition of a lipid antigen by CD1-restricted (αβ+) T cells. Nature 372, 691-694.
4. Beutler, E. (1997). The significance of the 187G (H63D) mutation in hemochromatosis. Am. J. Hum. Genet. 61, 762-764.
5. Borhani, D.W., and Harrison, S.C. (1991). Crystallization and X-ray diffraction studies of a soluble form of the human transferrin receptor. J. Mol. Biol. 218, 685-689.
6. Brunger, A.T. (1992a). XPLOR Version 3.1 A System for X-ray Crystallography and NMR. (New Haven: Yale University Press).
7. Brünger, A.T. (1992b). Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature 355, 472-475.
8. Burmeister, W.P., Gastinel, L.N., Simister, N.E., Blum, M.L., and Bjorkman, P.J. (1994a). Crystal structure at 2.2 Å resolution of the MHC-related neonatal Fc receptor. Nature 372, 336-343.
9. Burmeister, W.P., Huber, A.H., and Bjorkman, P.J. (1994b). Crystal structure of the complex of rat neonatal Fc receptor with Fc. Nature 372, 379-383.
10. Castaño, A.R., Tangri, S., Miller, J.E.W., Holcombe, H.R., Jackson, M.R., Huse, W.D., Kronenberg, M., and Peterson, P.A. (1995). Peptide binding and presentation by mouse CD1. Science 269, 223-226.
11. Chapman, T.L., and Bjorkman, P.J. (1998). Characterization of a murine cytomegalovirus class I major histocompatibility complex (MHC) homolog: comparison to MHC molecules and to the human cytomegalovirus MHC homolog. J. Virol. 72, 460-466.
12. Collins, E.J., Garboczi, D.N., and Wiley, D.C. (1994). Three-dimensional structure of a peptide extending from one end of a class I MHC binding site. Nature 371, 626-629.
13. Cowtan, K. (1994). Joint CCP4 and ESF-EACBM Newsletter on Protein Crystallography 31, 34-38.
14. Cuthbert, J.A. (1997). Iron, HFE, and hemochromatosis update. J. Invest. Med. 45, 518-529.
15. Enns, C.A., and Sussman, H.H. (1981). Physical characterization of the transferrin receptor in human placentae. J. Biol. Chem. 256, 9820-9823.
16. Feder, J.N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D.A., Basava, A., Dormishian, F., Domingo, R., Ellis, M.C., Fullan, A., et al. (1996). A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis. Nature Genet. 13, 399-408.
17. Feder, J.N., Tsuchihashi, Z., Irrinki, A., Lee, V.K., Mapa, F.A., Morikang, E., Prass, C.E., Starnes, S.M., Wolff, R.K., Parkkila, S., et al. (1997). The hemochromatosis founder mutation in HLA-H disrupts β2-microglobulin interaction and cell surface expression. J. Biol. Chem. 272, 14025-14028.
18. Feder, J.N., Penny, D.M., Irrinke, A., Lee, V.K., Lebrón, J.A., Watson, N., Tsuchihashi, Z., Sigal, E., Bjorkman, P.J., and Schatzman, R.C. (1998). The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc. Natl. Acad. Sci. USA 95, 1472-1477.
19. Fersht, A. (1985). Enzyme Structure and Mechanism, 2nd Edition. (New York: W.H. Freeman and Company).
20. Hashimoto, K., Hirai, M., and Kurosawa, Y. (1997). Identification of a mouse homolog for the human hereditary haemochromatosis candidate gene. Biochem. Biophys. Res. Comm. 230, 35-39.
21. Hodel, A., Kim, S.-H., and Brunger, A.T. (1992). Model bias in macromolecular structures. Acta Crystallogr. A 48, 851-858.
22. Howard, J.B., and Rees, D.C. (1991). Perspectives on non-heme iron protein chemistry. Adv. Protein Chem. 42, 199-280.
23. Jones, T.A., and Kjeldgaard, M. (1997). Electron density map interpretation. Meth. Enzymol. 277, 173-208.
24. Junghans, R.P. (1997). Finally! The Brambell receptor (FcRB). Mediator of transmission of immunity and protection from catabolism for IgG. Immunol. Res. 16, 29-57.
25. Karlsson, R., and Fält, A. (1997). Experimental design for kinetic analysis of protein-protein interactions with surface plasmon resonance biosensors. J. Immunol. Methods 200, 121-133.
26. Kleywegt, G.J. (1996). Use of non-crystallographic symmetry in protein structure refinement. Acta Crystallogr. D 52, 842-857.
27. Kleywegt, G.J., and Jones, T.A. (1996). Phi/Psi-chology: Ramachandran revisited. Structure 4, 1395-1400.
28. Kraulis, P. (1991). MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24, 946-950.
29. Kuziemko, G.M., Stroh, M., and Stevens, R.C. (1996). Cholera toxin binding affinity and specificity for gangliosides determined by surface plasmon resonance. Biochemistry 35, 6375-6384.
30. Madden, D.R., Garboczi, D.N., and Wiley, D.C. (1993). The antigenic identity of peptide-MHC complexes: a comparison of five viral peptides presented by HLA-A2. Cell 75, 693-708.
31. Malmqvist, M., and Granzow, R. (1994). Biomolecular interaction analysis. Methods 6, 95-98.
32. Matsumura, M., Fremont, D.H., Peterson, P.A., and Wilson, I.A. (1992). Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science 257, 927-934.
33. McLaren, G.D., Nathanson, M.H., Jacobs, A., Trevett, D., and Thomson, W. (1991 ). Regulation of intestinal iron absorption and mucosal iron kinetics in hereditary hemochromatosis. J. Lab. Clin. Med. 117, 390-410.
34. Merritt, E.A., and Murphy, M.E.P. (1994). Raster3D Version 2.0 - a program for photorealistic molecular graphics. Acta Crystallogr. D 50, 869-873.
35. Merryweather-Clarke, A.T., Pointon, J.J., Shearman, J.D., and Robson, K.J. (1997). Global prevalence of putative haemochromatosis mutations. J. Med. Genet. 34, 275-278.
36. Navaza, J. (1994). AMoRe: an automated package for molecular replacement. Acta Crystallogr. A 50, 157-163.
37. Nicholls, A., Sharp, K.A., and Honig, B.H. (1991). Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 11, 281-296.
38. Otwinowski, Z., and Minor, W. (1996). Processing of X-ray diffraction data collected in oscillation mode. Meth. Enzymol. 276, 307-326.
39. Parkkila, S., Waheed, A., Britton, R.S., Bacon, B.R., Zhou, X.Y., Tomatsu, S., Fleming, R.E., and Sly, W.S. (1997). Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis. Proc. Natl. Acad. Sci. USA 94, 13198-13202.
40. Rammensee, H.-G., Falk, K., and Rötzschke, O. (1993). Peptides naturally presented by MHC class I molecules. Annu. Rev. Immunol. 11, 213-244.
41. Richardson, D.R., and Ponka, P. (1997). The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. Biochim. Biophys. Acta 1331, 1-40.
42. Rötzschke, O., Falk, K., Deres, K., Schild, H., Norda, M., Metzger, J., Jung, G., and Rammensee, H.-G. (1990). Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature 348, 252-257.
43. Saper, M.A., Bjorkman, P.J., and Wiley, D.C. (1991). Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 Å resolution. J. Mol. Biol. 219, 277-319.
44. Schneider, C., Owen, M.J., Banville, D., and Williams, J.G. (1984). Primary structure of human transferrin receptor deduced from the mRNA sequence. Nature 311, 675-678.
45. Turkewitz, A.P., Amatruda, J.F., Borhani, D., Harrison, S.C., and Schwartz, A.L. (1988a). A high yield purification of the human transferrin receptor and properties of its major extracellular fragment. J. Biol. Chem. 263, 8318-8325.
46. Turkewitz, A.P., Schwartz, A.L., and Harrison, S.C. (1988b). A pH-dependent reversible conformational transition of the human transferrin receptor leads to self-association. J. Biol. Chem. 263, 16309-16315.
47. Vaughn, D.E., and Bjorkman, P.J. (1997). High affinity binding of the neonatal Fc receptor to its IgG ligand requires receptor immobilization. Biochemistry 36, 9374-9380.
48. Vaughn, D.E., and Bjorkman, P.J. (1998). Structural basis of pH dependent antibody binding by the neonatal Fc receptor. Structure 6, 63-73.
49. Waheed, A., Parkkila, S., Zhou, X.Y., Tomatsu, S., Tsuchihashi, Z., Feder, J.N., Schatzman, R.C., Britton, R.S., Bacon, B.R., and Sly, W.S. (1997). Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with β2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. Proc. Natl. Acad. Sci. USA 94, 12384-12389.
50. Zeng, Z.-H., Castaño, A.R., Segelke, B.W., Stura, E.A., Peterson, P.A., and Wilson, I.A. (1997). Crystal structure of mouse CD1: an MHC-like fold with a large hydrophobic binding groove. Science 277, 339-345.